China BlueChemical (OTCMKTS:CBLUY) Stock Price Down 28.3% - Should You Sell?

Key Points

• China BlueChemical shares fell 28.3% on Friday, dropping to $8.0240 from a previous close of $11.19.
• Trading volume was unusually low in absolute terms, with just 1 share changing hands, though that was far above the stock’s average session volume of 0 shares.
• The company’s balance sheet appears relatively solid, with a quick ratio of 4.32, current ratio of 4.62, and a low debt-to-equity ratio of 0.04.

Shares of China BlueChemical Ltd. (OTCMKTS:CBLUY - Get Free Report) traded down 28.3% during trading on Friday . The company traded as low as $8.0240 and last traded at $8.0240. 1 shares changed hands during mid-day trading, an increase of 1,900% from the average session volume of 0 shares. The stock had previously closed at $11.19.

China BlueChemical Price Performance

The company has a quick ratio of 4.32, a current ratio of 4.62 and a debt-to-equity ratio of 0.04. The stock has a 50 day simple moving average of $8.85 and a 200 day simple moving average of $8.65.

China BlueChemical Company Profile

China BlueChemical Co, Ltd. is a leading producer of nitrogen-based fertilizers and chemical products in the People’s Republic of China. The company’s core activities include the manufacturing and sale of nitrogenous fertilizers—such as urea, ammonium bicarbonate and ammonium sulfate—as well as methanol and related chemical intermediates. These products serve both the agricultural sector, where they are used to enhance crop yields, and various industrial applications, including chemical synthesis and fuel blending.

Headquartered in Zibo, Shandong Province, China BlueChemical operates multiple production facilities strategically located near natural gas supplies, which underpins its ammonia and methanol production processes.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.